Bone marrow transplantation (BMT) is an established therapeutic modality that may be life saving. 1, 2 However, risks and benefits to the recipient as well as risks to the donor must be considered. While bone marrow harvest rarely results in life-threatening complications or death in the donor, 1 little is known about bone marrow harvest during pregnancy. In some cases, alternative donors may not be available, and the recipient's condition may necessitate urgent BMT before a pregnant donor has delivered. To our knowledge, there are no reports of bone marrow harvest during pregnancy. Between June 1992 and April 2004, three HLA-matched related donors (Table 1) underwent successful bone marrow harvest during pregnancy at Vanderbilt University Medical Center.
Case #1: A 9-month-old girl with severe combined immunodeficiency syndrome presented with persistent polymicrobial pneumonia despite appropriate medical therapy. Urgent BMT was considered to treat her underlying immunodeficiency. HLA typing demonstrated that her 21-year-old mother, pregnant early in her first trimester, was HLA matched. Obstetric and anesthetic consultations were obtained. Risks to donor and fetus, including pregnancy loss, were carefully considered and explained at length to the mother. Owing to the urgent nature of the situation, a decision was made to proceed with harvest. Bone marrow harvest was performed at approximately 8 weeks gestation under epidural anesthesia with the donor in the prone position. No fetal monitoring was employed. Approximately 125 ml of bone marrow was obtained without difficulty via multiple bilateral iliac crest aspirations, and the donor received 1600 ml of intraoperative intravenous fluid. The donor tolerated the procedure well, was discharged later that day, and ultimately delivered a healthy baby boy at term. The recipient engrafted and is now 2 years post transplant off immune suppression.
Case #2: A 34-month-old boy with Glanzmann's thrombasthenia presented with recurrent life-threatening hemorrhages. Urgent BMT was considered to treat his underlying disease. HLA typing demonstrated that his 20-year-old mother, pregnant early in her third trimester, was HLA matched. Obstetric and anesthetic consultations were obtained. As the fetus was potentially viable, a neonatal intensive care unit (NICU) consultation was also obtained. Risks to donor and fetus, including premature delivery, were carefully considered and explained at length to the mother. Per NICU recommendation, harvest was delayed until approximately 28 weeks gestation to improve likelihood of neonatal survival in the event of premature delivery.
The bone marrow harvest was performed at approximately 28 weeks gestation under epidural anesthesia with the donor in left lateral decubitus position. Continuous fetal monitoring was employed. Obstetric staff members were present during the harvest for possible urgent surgical delivery in the event of fetal distress, and NICU staff members were immediately available. Approximately 260 ml of bone marrow was obtained via multiple right iliac crest aspirations, and the donor received 1800 ml of intraoperative intravenous fluid. Fetal heart rate remained 130-140 beats/minute with good variability throughout. The donor tolerated the procedure well, was discharged later that day, and ultimately delivered a healthy baby boy at 37 weeks gestation. The recipient engrafted and is now 5 months post transplant without recurrent bleeding.
Case #3: A 5-year-old boy with history of acute myelocytic leukemia required urgent BMT after failing induction chemotherapy. HLA typing demonstrated that the patient's 24-year-old mother, pregnant early in her third trimester, was a one-antigen mismatch at A locus. Obstetric and anesthetic consultations were obtained. Risks to donor and fetus, including premature delivery, were carefully considered and explained at length to the mother. Owing to the urgent nature of the situation, a decision was made to proceed with harvest. Bone marrow harvest was performed at approximately 28 weeks gestation under epidural anesthesia with the donor prone. No fetal monitoring was employed during the procedure. However, fetal monitoring was performed before and after the harvest as per the donor's request. Good fetal movement and heart rate were reported before and after the procedure. Approximately 350 ml of bone marrow was obtained without difficulty via multiple bilateral iliac crest aspirations, and the donor received 2200 ml of intraoperative intravenous fluid. The donor tolerated the procedure well and received one unit of autologous whole blood following the procedure. She was discharged the following day after overnight observation, and ultimately delivered a healthy baby boy at term. The recipient engrafted but subsequently died of graft-versushost disease.
Anesthesia and surgery during pregnancy may induce fetal distress and increase risk for pregnancy loss or premature delivery. 3 Furthermore, general anesthesia during pregnancy is associated with significant risk for pulmonary aspiration of gastric contents. 4 Bone marrow harvest during pregnancy should minimize risks to mother and fetus.
Obstetric and anesthetic consultations were obtained on our donors prior to donation and should be recommended for any woman considering bone marrow harvest during pregnancy. NICU consultation was obtained on one of two donors with a potentially viable fetus and is recommended for any woman with a potentially salvageable pregnancy. Harvest may be delayed if feasible to improve likelihood of neonatal survival. If the fetus is potentially viable, continuous fetal monitoring during harvest allows assessment of fetal distress; obstetric staff should be present and NICU staff immediately available for possible urgent surgical delivery. This is especially true if the donor consents for an emergent c-section during the harvest. General anesthesia should be avoided during pregnancy given the increased risk for pulmonary aspiration of gastric contents; 4 these harvests were successfully performed under epidural or spinal anesthesia. Careful monitoring of donor hemodynamics, and adequate intravenous fluid administration preserve uteroplacental perfusion and decrease risk of fetal distress. 3 Minimizing harvest volume may also prevent excessive perturbation of donor physiology. 
